A bi-adjuvant nanovaccine that potentiates immunogenicity of neoantigen for combination immunotherapy of colorectal cancer

Journal: Science Advances

Published: 2020-03-01

DOI: 10.1126/sciadv.aaw6071

Affiliations: 4

Authors: 12

Go to article
Institutions Share
NIH NIBIB Laboratory of Molecular Imaging and Nanomedicine (LOMIN), United States of America (USA) 0.63
Affiliated Jinling Hospital, NJU, China 0.21
VCU School of Pharmacy, United States of America (USA) 0.08
VCU Massey Cancer Center, United States of America (USA) 0.08